Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation
Condition(s):Paroxysmal Atrial FibrillationLast Updated:October 30, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Paroxysmal Atrial FibrillationLast Updated:October 30, 2023Terminated
Condition(s):Paroxysmal Atrial Fibrillation (PAF)Last Updated:November 8, 2023Completed
Condition(s):Atrial FibrillationLast Updated:February 7, 2022Completed
Condition(s):PainLast Updated:June 15, 2023Completed
Condition(s):Patent Foramen Ovale; Atrial Arrhythmia; Cryptogenic StrokeLast Updated:August 2, 2023Recruiting
Condition(s):Ventricular Premature Complexes; Outflow Tract; CarvedilolLast Updated:July 18, 2018Unknown status
Condition(s):Arrhythmogenic Right Ventricular CardiomyopathyLast Updated:September 9, 2022Completed
Condition(s):Persistent Atrial FibrillationLast Updated:April 10, 2014Unknown status
Condition(s):Ventricular Premature Complexes; Blood PressureLast Updated:February 22, 2019Terminated
Condition(s):Catecholaminergic Polymorphic Ventricular TachycardiaLast Updated:June 14, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.